BNP Paribas Financial Markets
USNA icon

BNP Paribas Financial Markets’s Usana Health Sciences USNA Stock Holding History

BNP Paribas Financial Markets’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.9K Buy
4,801
+2,052
+75% +$40.7K ﹤0.01% 4460
2025
Q4 		$54K Sell
2,749
-100
-4% -$2.08K ﹤0.01% 4650
2025
Q3 		$78.5K Sell
2,849
-6,394
-69% -$197K ﹤0.01% 4407
2025
Q2 		$282K Buy
9,243
+8,379
+970% +$238K ﹤0.01% 3640
2025
Q1 		$23.3K Sell
864
-18,552
-96% -$587K ﹤0.01% 4496
2024
Q4 		$697K Sell
19,416
-3,279
-14% -$123K ﹤0.01% 3068
2024
Q3 		$861K Sell
22,695
-5,544
-20% -$228K ﹤0.01% 2583
2024
Q2 		$1.28M Sell
28,239
-10,581
-27% -$487K ﹤0.01% 2149
2024
Q1 		$1.88M Buy
38,820
+5,952
+18% +$291K ﹤0.01% 2088
2023
Q4 		$1.76M Sell
32,868
-5,522
-14% -$279K ﹤0.01% 2045
2023
Q3 		$2.25M Buy
38,390
+10,822
+39% +$677K ﹤0.01% 1806
2023
Q2 		$1.74M Sell
27,568
-2,215
-7% -$141K ﹤0.01% 1838
2023
Q1 		$1.87M Buy
29,783
+7,279
+32% +$434K ﹤0.01% 1866
2022
Q4 		$1.2M Sell
22,504
-7,047
-24% -$382K ﹤0.01% 2062
2022
Q3 		$1.66M Buy
29,551
+8,270
+39% +$547K ﹤0.01% 2097
2022
Q2 		$1.54M Sell
21,281
-3,119
-13% -$232K ﹤0.01% 1918
2022
Q1 		$1.94M Buy
24,400
+549
+2% +$49.5K ﹤0.01% 1842
2021
Q4 		$2.41M Sell
23,851
-4,887
-17% -$487K ﹤0.01% 1863
2021
Q3 		$2.65M Buy
28,738
+13,206
+85% +$1.27M ﹤0.01% 1702
2021
Q2 		$1.59M Buy
15,532
+10,341
+199% +$1.04M ﹤0.01% 1881
2021
Q1 		$507K Buy
5,191
+1,058
+26% +$96.3K ﹤0.01% 2559
2020
Q4 		$319K Sell
4,133
-29
-0.7% -$2.24K ﹤0.01% 2680
2020
Q3 		$307K Buy
4,162
+2,163
+108% +$174K ﹤0.01% 2498
2020
Q2 		$147K Sell
1,999
-13,536
-87% -$1.06M ﹤0.01% 2616
2020
Q1 		$897K Buy
15,535
+11,716
+307% +$815K ﹤0.01% 1988
2019
Q4 		$300K Buy
3,819
+1,522
+66% +$112K ﹤0.01% 2767
2019
Q3 		$157K Sell
2,297
-88
-4% -$5.91K ﹤0.01% 2876
2019
Q2 		$189K Sell
2,385
-819
-26% -$65K ﹤0.01% 2659
2019
Q1 		$269K Buy
3,204
+2,189
+216% +$228K ﹤0.01% 2508
2018
Q4 		$119K Buy
1,015
+283
+39% +$32.7K ﹤0.01% 2255
2018
Q3 		$88.2K Sell
732
-388
-35% -$48.2K ﹤0.01% 2805
2018
Q2 		$129K Sell
1,120
-1,497
-57% -$164K ﹤0.01% 2658
2018
Q1 		$225K Sell
2,617
-30,806
-92% -$2.39M ﹤0.01% 2725
2017
Q4 		$2.47M Buy
33,423
+31,669
+1,806% +$2.12M ﹤0.01% 1372
2017
Q3 		$101K Sell
1,754
-357
-17% -$21.1K ﹤0.01% 2779
2017
Q2 		$135K Buy
2,111
+245
+13% +$15.1K ﹤0.01% 2662
2017
Q1 		$107K Sell
1,866
-517
-22% -$30.9K ﹤0.01% 2466
2016
Q4 		$146K Buy
2,383
+1,025
+75% +$66.8K ﹤0.01% 2360
2016
Q3 		$93.9K Buy
1,358
+420
+45% +$27.7K ﹤0.01% 2133
2016
Q2 		$52.3K Buy
938
+670
+250% +$40.4K ﹤0.01% 2291
2016
Q1 		$16.3K Sell
268
-3,036
-92% -$179K ﹤0.01% 2175
2015
Q4 		$211K Buy
3,304
+116
+4% +$7.52K ﹤0.01% 1894
2015
Q3 		$214K Buy
3,188
+1,546
+94% +$109K ﹤0.01% 1910
2015
Q2 		$112K Buy
1,642
+1,360
+482% +$86.3K ﹤0.01% 2029
2015
Q1 		$15.7K Sell
282
-8,760
-97% -$449K ﹤0.01% 2494
2014
Q4 		$464K Sell
9,042
-1,574
-15% -$77.3K ﹤0.01% 1154
2014
Q3 		$391K Buy
10,616
+1,400
+15% +$50.5K ﹤0.01% 1616
2014
Q2 		$360K Buy
9,216
+356
+4% +$13.2K ﹤0.01% 1616
2014
Q1 		$301K Buy
+8,860
New +$309K ﹤0.01% 1659

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BNP Paribas Financial Markets's USNA Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Usana Health Sciences (USNA) stake by 75% in Q1 2026, buying an estimated $40.7K and bringing the position to 4,801 shares worth $83.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4460.

BNP Paribas Financial Markets first reported a position in USNA in Q1 2014 and has held it in 49 quarters since. The position peaked at $2.65M in Q3 2021. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • BNP Paribas Financial Markets held 4,801 shares of Usana Health Sciences worth $83.9K as of Q1 2026.
  • BNP Paribas Financial Markets bought 2,052 Usana Health Sciences shares in Q1 2026, an estimated $40.7K.
  • Usana Health Sciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #4460 holding.
  • BNP Paribas Financial Markets first reported a position in Usana Health Sciences in Q1 2014 and has held it in 49 quarters since.
  • BNP Paribas Financial Markets's Usana Health Sciences position peaked at $2.65M in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.